Inactive Instrument

CM LIFE

Equities

CMLT

US1258411065

CM Life Sciences III Inc. announced that it has received $163.04 million in funding from CMLS Holdings III LLC, Casdin Capital, LLC, Corvex Management LP and other investors

April 05, 2021

On April 6, 2021, CM Life Sciences III Inc. (NasdaqCM:CMLT) closed the transaction. The company issued 8,693,333 warrants for gross proceeds of $13,400,000. The transaction included participation from Casdin Capital, LLC for 7,500,000 class A share for $75,000,000 and Corvex Management LP for 7,500,000 class A share for $75,000,000

Latest news about CM LIFE

Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company	21-12-17	MT
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index	21-12-17	CI
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.	21-12-16	CI
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	21-12-02	CI
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines	21-10-19	MT
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021.	21-10-03	CI
CM Life Sciences III : Agree to Business Combination; Shares Rise Early	21-08-06	MT
EQRx, Inc. executed a non-binding Letter of intent to acquire CM Life Sciences III Inc. from CMLS Holdings III LLC and others for $4.2 billion in a reverse merger transaction.	21-08-05	CI
CM Life Sciences III Inc. Appoints Amy Abernethy as Director	21-08-03	CI
CM Life Sciences III Inc.(NasdaqCM:CMLT) added to NASDAQ Composite Index	21-06-02	CI
CM Life Sciences III Inc. has completed an IPO in the amount of $480 million.	21-04-07	CI
CM Life Sciences III Inc. announced that it has received $163.04 million in funding from CMLS Holdings III LLC, Casdin Capital, LLC, Corvex Management LP and other investors	21-04-05	CI
CM Life Sciences III Inc. has filed an IPO in the amount of $400 million.	21-02-24	CI
CM Life Sciences III Inc. announced that it expects to receive $160.000001 million in funding from CMLS Holdings III LLC, Casdin Capital, LLC, Corvex Management LP and other investors	21-02-23	CI

Chart CM LIFE

Duration

Period

More charts

Company Profile

CM Life Sciences III Inc is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target. The Company intends to execute business combination in the life sciences sector.

Sector

More about the company